Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

QGEN Qiagen NV

0.06 (0.14%)
Dec 04 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Qiagen NV QGEN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 0.14% 41.51 17:30:00
Open Price Low Price High Price Close Price Prev Close
41.43 41.26 41.67 41.51 41.45
more quote information »

Recent News

Date Time Source Heading
11/30/202316:05GLOBEDNA Labs International solves significant cold cases with..
11/15/202316:05GLOBEQIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro..
11/09/202316:05GLOBEQIAGEN launches new QIAcuity digital PCR kits and updated..
11/06/202316:05GLOBEQIAGEN launches complete Sample to Insight workflow for..
11/02/202308:00PRNUSQIAGEN and Element Biosciences partner to offer complete..
10/30/202316:05GLOBEQIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth..
10/26/202308:00GLOBEQIAGEN and Myriad Genetics partner to advance companion..
10/09/202311:14GLOBEQIAGEN N.V. to release results for Q3 2023 and hold webcast
10/04/202316:05GLOBEQIAGEN launches QuantiFERON-EBV RUO assay, facilitating..
9/28/202316:05GLOBEQIAGEN extends AI capabilities of its NGS interpretation..
9/27/202316:05GLOBEQIAGEN reports progress toward achieving Environmental,..
9/25/202316:05GLOBEQIAGEN enhances QIAwave portfolio with new eco-friendlier..
8/25/202316:48EDGAR2Form 144 - Report of proposed sale of securities
8/09/202321:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202321:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/08/202316:05GLOBEQIAGEN delivers ahead of outlook for Q2 2023 with 9% CER..
8/07/202316:05GLOBEQIAGEN receives FDA approval for companion diagnostic to..
7/26/202316:15BWBio-Rad and QIAGEN Announce Patent Settlement and..
7/24/202307:41GLOBEQIAGEN N.V. to release results for Q2 2023 and hold webcast
7/18/202316:05GLOBEQIAGEN expands range of digital PCR kits and services for..
6/20/202316:05GLOBEFBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow..
6/16/202307:36GLOBEQIAGEN provides reminder on settlement mechanics of 2023 and..
6/15/202316:05GLOBEQIAGEN’s QuantiFERON-TB Gold Plus shows unique clinical..
6/13/202316:05GLOBEDanish National Genome Center selects QIAGEN for variant..
5/03/202316:05GLOBEQIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth..
5/03/202305:30GLOBEQIAGEN welcomes U.S. Preventive Services Task Force..
4/24/202316:05GLOBEQIAGEN launches QIAstat-Dx in Japan with respiratory panel..
4/20/202316:05GLOBEQIAGEN announces expansion of Supervisory Board
4/14/202306:00GLOBEQIAGEN showcases latest technologies to advance cancer..
3/13/202308:01BWQIAGEN Announces Form 20-F Annual Report Filing for 2022..
3/09/202301:30BWQIAGEN und Servier entwickeln Begleitdiagnostikum für..
3/01/202309:00BWQIAGEN and SOPHiA GENETICS Forge Partnership to Combine..
2/14/202316:05BWQIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus..
2/07/202316:05BWQIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022..
1/17/202316:05BWQIAGEN Launches EZ2 Connect MDx Platform for Automated..
1/17/202306:38BWQIAGEN N.V. to Release Results for Q4 and Full-Year Results..
1/09/202302:00BWQIAGEN schließt Übernahme von Verogen ab und stärkt führende..
1/05/202316:05BWQIAGEN und Helix vereinbaren exklusive Partnerschaft, um..
12/13/202205:00BWQIAGEN receives FDA approval for companion diagnostic to..

Your Recent History

Delayed Upgrade Clock